After a DESeq2 run completed, Orbit summarized results in a way that was initially biologically misleading: genes were described as "downregulated" in a condition based on negative log2 fold-change, without stating the contrast direction. It later clarified the contrast was computed as log2(Control/Treatment), so negative values actually meant higher expression in the treatment condition. The underlying numbers were correct -- only the interpretation was wrong because the contrast direction wasn't stated.
Orbit should explicitly display the fold-change definition (e.g. log2(Control/Treatment) vs log2(Treatment/Control)) before labeling genes up/down-regulated, so the narrative can't invert the biology.
Same scientific-correctness-guardrail family as #220. Surfaced alongside the sample-labeling issue #288.
After a DESeq2 run completed, Orbit summarized results in a way that was initially biologically misleading: genes were described as "downregulated" in a condition based on negative log2 fold-change, without stating the contrast direction. It later clarified the contrast was computed as
log2(Control/Treatment), so negative values actually meant higher expression in the treatment condition. The underlying numbers were correct -- only the interpretation was wrong because the contrast direction wasn't stated.Orbit should explicitly display the fold-change definition (e.g.
log2(Control/Treatment)vslog2(Treatment/Control)) before labeling genes up/down-regulated, so the narrative can't invert the biology.Same scientific-correctness-guardrail family as #220. Surfaced alongside the sample-labeling issue #288.